Neurocrine Biosciences, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was USD 310.6 million compared to USD 236.6 million a year ago. Net income was USD 13.9 million compared to USD 32.1 million a year ago. Basic earnings per share from continuing operations was USD 0.15 compared to USD 0.34 a year ago. Diluted earnings per share from continuing operations was USD 0.14 compared to USD 0.33 a year ago.